Targeted News Service

FDA Center for Drug Evaluation & Research Issues Warning Letter to Mile High Compounds
April 08, 2026

WASHINGTON, April 8 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Mile High Compounds LLC from its Center for Drug Evaluation and Research:

* * *

Recipient: Max Radovanic, Mile High Compounds LLC, 490 Aspen Grove Dr., Clifton, CO 81520, United States, support@milehighcompounds.is

Issuing Office: Center for Drug Evaluation and Research (CDER), United States

WARNING LETTER< . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form